AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) and Astellas Pharma Inc. Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting

Posted: May 16th, 2013  |  Company/topic: Astellas
Website: BioSpace.com Featured News
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced that additional data from t…
Tags: , ,

AstraZeneca PLC, Cubist Pharmaceuticals, Inc., Astellas Pharma Inc. Said to Make Bids for Optimer Pharmaceuticals, Inc.

Posted: May 15th, 2013  |  Company/topic: AstraZeneca
Website: BioSpace.com Featured News
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!AstraZeneca Plc (AZN) and Cubist Pharmaceuticals Inc. (CBST) are among the suitors that made first-round bids…
Tags: , ,

Astellas Pharma Inc. Joins the

Posted: May 14th, 2013  |  Company/topic: Astellas
Website: BioSpace.com Featured News
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!WASHINGTON, May 14, 2013 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced…
Tags: , ,

Astellas Announces Cancellation of Treasury Stock

Posted: May 13th, 2013  |  Company/topic: Astellas
Website: Bioportfolio Latest News
Tokyo Japan May 13 2013 – Astellas Pharma Inc. Tokyo 4503; President and CEO Yoshihiko Hatanaka hereinafter called “the Company” announced that at the meeting of the Boar…
Tags: , ,